First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus.

AT-752 - Atea Pharma

http://www.ncbi.nlm.nih.gov/pubmed/38526047

Arantxa Horga; Bruce Belanger; Dayle James; Janet Hammond; Jason Lickliter; Keith Pietropaolo; Laura Ishak; Maureen Montrond; Xiao-Jian Zhou

Mar 25, 2024